Christoph Brackmann is CFO at NovoCure Ltd (NVCR). They have made 2 open-market trades across 1 company since 2025, most recently 2026-03-04.
CIK 0002048634
1 open-market purchase totalling $348K since 2025, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NVCR | 189,254 | $2.7M |
Shares reported on the most recent Form 4, priced at the 2026-03-05 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.